Efruxifermin Clinical Trials (2026): 4 Studies for NASH - Nonalcoholic Steatohepatitis & MASH - Metabolic Dysfunction-Associated Steatohepatitis

Where to Participate: All Efruxifermin Trial Sites in the U.S. (327 sites across 35 states)

Every actively recruiting Efruxifermintrial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.

Efruxifermin clinical trials at a glance: phase × recruitment status

Recruiting Efruxifermin clinical trials (2)

Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).

Efruxifermin clinical trials by indication

Efruxifermin pivotal trial highlights (Phase 2/3/4)

Phase-2/3/4 studies with named acronyms — the registration-grade trials most cited in label discussions and Wikipedia.

All Efruxifermin trials (4)

Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.

Efruxifermin clinical trials: frequently asked questions

How many Efruxifermin clinical trials are there?

4 Efruxifermin clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 2 are actively recruiting participants. 1 is marked completed.

Are Efruxifermin clinical trials recruiting in 2026?

Yes — 2 Efruxifermin trials are actively recruiting in 2026, with 327 U.S. sites across 35 states. See the recruiting trials and the per-state site list further down this page.

What conditions is Efruxifermin being studied for?

Efruxifermin is being studied for NASH - Nonalcoholic Steatohepatitis, MASH - Metabolic Dysfunction-Associated Steatohepatitis, MASH With Fibrosis, NAFLD/MASLD, NASH With Fibrosis and 1 more. The trials are grouped by indication on this page.

What phase is Efruxifermin in?

Efruxifermin clinical trials span 3 Phase 3, 1 Phase 2. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.

Who sponsors Efruxifermin clinical trials?

The lead sponsor across the most Efruxifermin trials is Akero Therapeutics, Inc. Each trial row links to the full study detail page including sponsor information.

Sources and methodology

Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming Efruxiferminas an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.

Last refreshed June 18, 2026.